Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Fact Sheets & Publications

About IAVI

IAVI is a nonprofit organization dedicated to developing vaccines and antibodies for HIV, tuberculosis, emerging infectious diseases, and neglected diseases. Our mission is to translate scientific discoveries into affordable, globally accessible public health solutions.

Read more

Fact Sheets & Publications

The world needs an HIV vaccine

The only way to end HIV/AIDS as a public health problem of global importance is with a vaccine. IAVI remains committed to developing a safe, effective, globally useful one.

Read more

Fact Sheets & Publications

The urgent need for a TB vaccine

A vaccine is necessary to end the TB epidemic. IAVI and partners continue to make strides to reach this goal.

Read more

Fact Sheets & Publications

Emerging infectious diseases vaccines

IAVI is applying its vaccine development expertise and working with a group of expert international partners to develop vaccines to prevent emerging infectious diseases.

Read more

Fact Sheets & Publications

Antibodies for HIV prevention

IAVI and partners are applying their expertise gained from HIV vaccine research to produce what could be a breakthrough in the fight against HIV/AIDS: an injection of bnAbs to prevent HIV infection.

Read more

Fact Sheets & Publications

Coronavirus vaccine program

IAVI and partners are leveraging our extensive vaccine development expertise to develop a vaccine to prevent COVID-19, with a focus on equitable global access.

Read more

Fact Sheets & Publications

IAVI Design and Development Lab

The IAVI Vaccine Design and Development Lab generates and develops innovative HIV and emerging infectious diseases vaccine candidates to address global public health needs.

Read more

Fact Sheets & Publications

ADVANCE

ADVANCE (Accelerate the Development of Vaccines and New Technologies to Combat the AIDS Epidemic) is a 10-year cooperative agreement with the U.S. Agency for International Development, through PEPFAR.

Read more